The Relationship of Medication Adherence and Social Functioning of Persons with Schizophrenia in the Long-term Period
DOI:
https://doi.org/10.3889/oamjms.2021.6302Keywords:
Medication adherence, Social functioning, Schizophrenia, Long-term periodAbstract
BACKGROUND: Medication adherence is an essential aspect of the daily lives of persons with schizophrenia, while in-compliance is related to their social functioning performance.
AIM: The study aims to analyze the prolonged relationship between medication adherence and the social functioning of persons with chronic schizophrenia.
METHODS: A descriptive correlation method was carried out on 60 persons with schizophrenia at Pasung in North Sumatra Province, Indonesia, using questionnaires.
RESULTS: The results indicate that 68.3–51.7% of respondents had low adherence to medication and social functioning, respectively. Spearman rank claimed that there is a strong relationship between medication adherence and social functioning among chronic schizophrenia persons. Furthermore, the result reported that medication adherence positively affected social functioning among persons with schizophrenia.
CONCLUSIONS: Medication adherence is a priority for maintaining the behavior of people living with schizophrenia to help them control their psychotic symptoms. Therefore, it can enhance their social functioning performance and daily living activity. Family participation is needed for continuous medication program and relapse rate prevention.Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Stuart GW, Laraia MT. Principles and Practice of Psychiatric Nursing. St. Louis: Mosby; 2013.
NIHRD (National Institute of Health Research and Development) Ministry of Health of Republic of Indonesia. Basic Health Research Report; 2018. Available from: https://www.kesmas.kemkes.go.id/assets/upload/dir_519d41d8cd98f00/files/Hasil-riskesdas-2018_1274.pdf. [Last accessed on 2020 Aug 12].
Yulianti MD, Cahaya N, Srikartika VM. Antipsychotics use and side effects in patients with schizophrenia at Sambang Lihum Hospital South Kalimantan, Indonesia. J Sains Farm Klin. 2017;3(2):153-64. https://doi.org/10.29208/jsfk.2017.3.2.108 DOI: https://doi.org/10.29208/jsfk.2017.3.2.108
Hu Y, Young AJ, Ehli EA, Nowotny D, Davies PS, Droke EA, et al. Metformin and berberine prevent olanzapine-induced weight gain in rats. PLoS One. 2014;9:e93310. PMid:24667776 DOI: https://doi.org/10.1371/journal.pone.0093310
Lachaine J, Yen L, Beauchemin C, Hidgkins P. Medication adherence and persistence in the treatment of Canadian ulcerative colitis patients: Analyses with the RAMQ database. BMC Gastroenterol. 2013;13:23. https://doi.org/10.1186/1471-230x-13-23 PMid:23363459 DOI: https://doi.org/10.1186/1471-230X-13-23
Zeber JE, Manias E, Williams AF, Hutchins D, Udezi WA, Roberts CS, et al. Medication adherence: A report of the ISPOR medication adherence and persistence special interest group. Value Health. 2013;16(5):891-90. https://doi.org/10.1016/j.jval.2013.04.014 PMid:23947984 DOI: https://doi.org/10.1016/j.jval.2013.04.014
Purba J, Suttharangsee W, Chaowalit A. Effectiveness of a coaching program for family caregivers of persons with schizophrenia: A randomized controlled trial. Walailak J Sci Tech 2017;14(1):11-24.
Settem VVJ, Karanadi H, Praharaj SK. Cognitive deficits, depressive symptoms, insight, and medication adherence in remitted patients with schizophrenia. Indian J Psychiatry. 2019;61(4):335-41. https://doi.org/10.4103/psychiatry.indianjpsychiatry_17_19 PMid:31391635 DOI: https://doi.org/10.4103/psychiatry.IndianJPsychiatry_17_19
Purba JM, Simamora RH, Karota E, Siregar CT. Family support for persons with schizophrenia after physical restraint and confinement. Enferm Clin. 2020;30(Suppl 3):53-6. https://doi.org/10.1016/j.enfcli.2019.12.026 DOI: https://doi.org/10.1016/j.enfcli.2019.12.026
Popp BS, Minodora M, Moraru MO. Treatment adherence and social functioning in patients diagnosed with schizophrenia and treated with antipsychotic depot medication. Clujul Med. 2014;87(2):109-12. https://doi.org/10.15386/cjmed-292 PMid:26528009 DOI: https://doi.org/10.15386/cjmed-292
Ozkan B, Erdem E, Ozsoy SD, Zararsiz G. The effects of psychoeducation and telepsychiatric follow-up on social functioning and medication adherence in the patients with schizophrenia. Anadolu Psikiyatr Derg. 2013;14(3):192-9. https://doi.org/10.5455/apd.35951 DOI: https://doi.org/10.5455/apd.35951
Xiao J, Mi W, Li L, Shi Y, Zhang H. High relapse rate and poor medication adherence in the Chinese population with schizophrenia: Results from an observational survey in the People’s Republic of China. Neuropsychiatr Dis Treat. 2015;11:1161-7. https://doi.org/10.2147/ndt.s72367 PMid:26056450 DOI: https://doi.org/10.2147/NDT.S72367
Dushad R, Mintu M, Samaksha PB, Basavana GH. A study of drug attitude and medication adherence and its relationship with the impact of illness among the mentally ill. Arch Clin Psychiatry. 2019;46(4):85-8. https://doi.org/10.1590/0101-60830000000201 DOI: https://doi.org/10.1590/0101-60830000000201
Kaplan G, Casov J, Zummo J. Impact of long-acting injectable antipsychotics on medication adherence and clinical functional, and economic outcomes of schizophrenia. Patient Prefer Adherence. 2013;7:1171-80. https://doi.org/10.2147/ppa.s53795 PMid:24265549 DOI: https://doi.org/10.2147/PPA.S53795
Duțescu MM, Popescu RE, Balcu L, Duica LC, Strunoiu LM, Alexandru DO, et al. Social functioning in schizophrenia clinical correlations. Curr Health Sci J. 2018;44(2):151-6. PMid:30746163
Lasebikan VO, Ayinde OO. Effects of psychopathology, functioning and antipsychotic medication adherence on caregivers’ burden in schizophrenia. Indian J Psychol Med. 2013;35(2):135-40. DOI: https://doi.org/10.4103/0253-7176.116237
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2021 Jenny Marlindawani Purba, Roymond H. Simamora, Evi Karota (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
http://creativecommons.org/licenses/by-nc/4.0
